Results 61 to 70 of about 18,836 (198)

Mycetoma: A Narrative Review of Its Clinical and Epidemiological Spectrum With a Focus on Iran

open access: yesHealth Science Reports, Volume 9, Issue 11, November 2026.
ABSTRACT Background and Aims Mycetoma is a chronic, neglected tropical disease affecting the skin and subcutaneous tissues, capable of extending to deeper structures. It exists in two forms: eumycetoma (fungal) and actinomycetoma (bacterial). This review aims to examine the epidemiology, causative organisms, pathogenesis, clinical features, diagnosis ...
Shabnam Rezaei   +4 more
wiley   +1 more source

Posaconazole binding.

open access: yes, 2013
Stereoscopic view of posaconazole in chain B (A) and in chain D (B) surrounded by the side chains within 4 Å. Image in B is rotated ∼90° to the right along the vertical axis in the plane of drawing.
Matthew P. Jacobson (174588)   +5 more
core   +1 more source

Intravenous and tablet formulation of posaconazole in antifungal therapy and prophylaxis: A retrospective, non-interventional, multicenter analysis of hematological patients treated in tertiary-care hospitals

open access: yesInternational Journal of Infectious Diseases, 2019
Objectives: Novel formulations (gastro-resistant tablet and intravenous solution) of posaconazole (POS) have been approved in prophylaxis and therapy of invasive fungal diseases (IFDs).
Sebastian M. Heimann   +7 more
doaj   +1 more source

Discrepant Urinary Findings Between Dipstick Protein and Sulfosalicylic Acid Test in a Patient With Hyaline Casts: A Case Report

open access: yesJournal of Clinical Laboratory Analysis, Volume 40, Issue 21, November 2026.
In this post‐transplant patient, increased hyaline casts with negative dipstick protein but positive SSA testing occurred during evolving acute kidney injury and resolved with renal recovery. This discordant urinalysis pattern may warrant confirmatory protein testing and correlation with serial renal function in patients at high risk of AKI.
Yifei Jia   +6 more
wiley   +1 more source

Posaconazole trough concentrations are not influenced by inflammation:a prospective study [PDF]

open access: yes, 2019
BACKGROUND: During inflammation several cytochrome P450 enzymes are down-regulated. Recently it was shown that voriconazole metabolism is reduced during inflammation.
C. Alffenaar, Jan Willem   +23 more
core   +1 more source

Pharmacologic and clinical evaluation of posaconazole. [PDF]

open access: yes, 2016
Posaconazole, a broad-spectrum triazole antifungal agent, is approved for the prevention of invasive aspergillosis and candidiasis in addition to the treatment of oropharyngeal candidiasis. There is evidence of efficacy in the treatment and prevention of
Healy, Jason R.   +2 more
core   +1 more source

Enhanced antifungal activity of posaconazole against Candida auris by HIV protease inhibitors, atazanavir and saquinavir

open access: yesScientific Reports
The increasing incidence and dissemination of multidrug-resistant Candida auris represents a serious global threat. The emergence of pan-resistant C. auris exhibiting resistance to all three classes of antifungals magnifies the need for novel therapeutic
Yehia Elgammal   +2 more
doaj   +1 more source

Cutaneous Alternariosis

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Kaan Yilmaz   +2 more
wiley   +1 more source

Machine Learning–Augmented Precision Dosing: Integrating Pharmacokinetic Modeling With Clinical Decision Support

open access: yesCPT: Pharmacometrics &Systems Pharmacology, Volume 15, Issue 11, November 2026.
ABSTRACT Inter‐individual variability in drug exposure can lead to ineffective therapy or toxicity, particularly in vulnerable patients. Routine model‐informed precision dosing (MIPD) relies mainly on population pharmacokinetic (PopPK) models, Bayesian forecasting, and therapeutic drug monitoring (TDM).
Yunmeng Pang   +5 more
wiley   +1 more source

Chemical structures of posaconazole and fluconazole.

open access: yes, 2013
Chemical structures of posaconazole and fluconazole.
Matthew P. Jacobson (174588)   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy